Manulife (Manufacturers Life Insurance)
ARGS

Manulife (Manufacturers Life Insurance)’s Argos Therapeutics, Inc. ARGS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-53
Closed – – 4512
2017
Q2 		$0 Sell
53
-6
-10% -$51 ﹤0.01% 4609
2017
Q1 		$1K Hold
59
– – ﹤0.01% 4177
2016
Q4 		$6K Buy
59
+11
+23% +$1.03K ﹤0.01% 3914
2016
Q3 		$5K Buy
+48
New +$5.01K ﹤0.01% 3908
2014
Q4 		– Sell
-13
Closed -$3 – 4220
2014
Q3 		$3 Buy
+13
New +$2.03K ﹤0.01% 3745

Other funds holding ARGS

PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ARGS Position: Q3 2017 in Review

Manulife (Manufacturers Life Insurance) sold out of Argos Therapeutics, Inc. (ARGS) in Q3 2017, closing a stake of 53 shares.

Manulife (Manufacturers Life Insurance) first reported a position in ARGS in Q3 2014 and held it in 5 quarters. The position peaked at $6K in Q4 2016. 29 funds tracked by Wall St. Rank hold ARGS as of Q3 2017.

  • Manulife (Manufacturers Life Insurance) reported no remaining Argos Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 53 Argos Therapeutics, Inc. shares in Q3 2017.
  • Manulife (Manufacturers Life Insurance) first reported a position in Argos Therapeutics, Inc. in Q3 2014 and held it in 5 quarters.
  • Manulife (Manufacturers Life Insurance)'s Argos Therapeutics, Inc. position peaked at $6K in Q4 2016.
  • 29 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q3 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2017, filed 14 Nov 2017.